Becton Dickinson shares jump after FDA ruling on its infusion system

Key things The FDA has granted 501(k) clearance to Becton Dickinson’s updated BD Alaris infusion system. The system faced several appeals, and CEO Tom Polen said the update was targeting them. Becton Dickinson shares rose to their highest level since 2020 on the news. Becton Dickinson (BDX) was the best-performing stock in the S&P 500 […]